3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Colorectal Neoplasms
3
Uterine Cervical Neoplasms
2
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Ewing
1
Recurrence
1
Rectal Diseases
1
Pancreatic Neoplasms
1
Neoplasms by Site
1
Nasopharyngeal Carcinoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Graft vs Host Disease
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Gastric Cancer With Liver Metastases
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Interventions
pembrolizumab
2
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
2
Gemcitabine
2
somatostatin, cyclic hexapeptide(Phe-Phe-Trp-Lys-Thr-Phe)-
1
sodium-iodide symporter
1
fludarabine
1
duvelisib
1
cemiplimab
1
X-Rays
1
Specimen Handling
1
Photons
1
Oxaliplatin
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Disulfides
1
Cyclophosphamide
1
Brentuximab Vedotin
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Peripheral
×
Drug Therapy
×
30 days
×
Clear all
No trials found.